Search research articles
Contact Us
Filters
Showing results (31-40 of 61) with videos related to
Page
of 7
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 12, 2021
Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine
Caroline B Pantazis, Morgan H James, Shayna O'Connor, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 19, 2016
Prelimbic to Accumbens Core Pathway Is Recruited in a Dopamine-Dependent Manner to Drive Cued Reinstatement of Cocaine Seeking
Ellen M McGlinchey, Morgan H James, Stephen V Mahler, et al.
Biology of Sex Differences
|
July 19, 2024
Sex differences in the social motivation of rats: Insights from social operant conditioning, behavioural economics, and video tracking
Joel S Raymond, Simone Rehn, Morgan H James, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Reducing astrocyte calcium in the nucleus accumbens core increases reward valuation
Jonathan W VanRyzin, Gabrielle A Laraia, Utsav Gyawali, et al.
The International Journal of Neuropsychopharmacology
|
November 23, 2017
Cued Reinstatement of Cocaine but Not Sucrose Seeking Is Dependent on Dopamine Signaling in Prelimbic Cortex and Is Associated with Recruitment of Prelimbic Neurons That Project to Contralateral Nucleus Accumbens Core
Morgan H James, Ellen M McGlinchey, Asrita Vattikonda, et al.
Addiction Neuroscience
|
September 27, 2023
Recent advances in drug discovery efforts targeting the sigma 1 receptor system: Implications for novel medications designed to reduce excessive drug and food seeking
Liam G Knowles, Abanoub J Armanious, Youyi Peng, et al.
Nature Neuroscience
|
September 26, 2014
Motivational activation: a unifying hypothesis of orexin/hypocretin function
Stephen V Mahler, David E Moorman, Rachel J Smith, et al.
ACS Sustainable Chemistry & Engineering
|
July 9, 2021
Construction of a Virtual Opioid Bioprofile: A Data-Driven QSAR Modeling Study to Identify New Analgesic Opioids
Xuelian Jia, Heather L Ciallella, Daniel P Russo, et al.
Frontiers in Neuroscience
|
March 12, 2014
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
Jiann Wei Yeoh, Erin J Campbell, Morgan H James, et al.
Neuropharmacology
|
October 22, 2020
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H James, Jennifer E Fragale, Shayna L O'Connor, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 61) with videos related to
Sort By:
Page
of 7
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 12, 2021
Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine
Caroline B Pantazis, Morgan H James, Shayna O'Connor, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 19, 2016
Prelimbic to Accumbens Core Pathway Is Recruited in a Dopamine-Dependent Manner to Drive Cued Reinstatement of Cocaine Seeking
Ellen M McGlinchey, Morgan H James, Stephen V Mahler, et al.
Biology of Sex Differences
|
July 19, 2024
Sex differences in the social motivation of rats: Insights from social operant conditioning, behavioural economics, and video tracking
Joel S Raymond, Simone Rehn, Morgan H James, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Reducing astrocyte calcium in the nucleus accumbens core increases reward valuation
Jonathan W VanRyzin, Gabrielle A Laraia, Utsav Gyawali, et al.
The International Journal of Neuropsychopharmacology
|
November 23, 2017
Cued Reinstatement of Cocaine but Not Sucrose Seeking Is Dependent on Dopamine Signaling in Prelimbic Cortex and Is Associated with Recruitment of Prelimbic Neurons That Project to Contralateral Nucleus Accumbens Core
Morgan H James, Ellen M McGlinchey, Asrita Vattikonda, et al.
Addiction Neuroscience
|
September 27, 2023
Recent advances in drug discovery efforts targeting the sigma 1 receptor system: Implications for novel medications designed to reduce excessive drug and food seeking
Liam G Knowles, Abanoub J Armanious, Youyi Peng, et al.
Nature Neuroscience
|
September 26, 2014
Motivational activation: a unifying hypothesis of orexin/hypocretin function
Stephen V Mahler, David E Moorman, Rachel J Smith, et al.
ACS Sustainable Chemistry & Engineering
|
July 9, 2021
Construction of a Virtual Opioid Bioprofile: A Data-Driven QSAR Modeling Study to Identify New Analgesic Opioids
Xuelian Jia, Heather L Ciallella, Daniel P Russo, et al.
Frontiers in Neuroscience
|
March 12, 2014
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
Jiann Wei Yeoh, Erin J Campbell, Morgan H James, et al.
Neuropharmacology
|
October 22, 2020
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H James, Jennifer E Fragale, Shayna L O'Connor, et al.
Page
of 7